EBC is a network of key players in the “Brain Area”, with a membership encompassing scientific societies, patient organisations, professional societies and industry partners.
This year’s Brain Innovation Days event will centre around Connecting Brains; bringing together the current and future generations of brain research and innovation. The focus of the 2022 event will be to enable space and opportunity for open discussion and showcasing, prioritising matchmaking and networking within the community, particularly of stakeholders who may not have the opportunity to connect in [...]
The European Brain Research Area (EBRA) project partners are delighted to invite you to the upcoming Final Conference, which will take place on 11 October 2022 in Brussels, Belgium. Four years have already passed and plenty of work is to be presented this coming October, including the EBRA Landscape Analysis, the Shared European Brain Research Agenda (SEBRA) [...]
The annual European College of Neuropsychopharmacology (ECNP) Congress is Europe’s premier scientific meeting for disease-oriented brain research, annually attracting more than 5,000 psychiatrists, neuroscientists, neurologists and psychologists from around the world. The European College of Neuropsychopharmacology (ECNP) is an independent scientific association dedicated to the science and treatment of disorders of the [...]
The European Congress of Neurosurgery 2022 (EANS2022) took place on 16-20 October in Belgrade, Serbia. The European Association of Neurosurgical Societies (EANS) is both an independent federation of European national neurosurgical societies and a fast-developing association of individual neurosurgeons from around the world. The Congress theme – Trends, Insights, Innovations: Neurosurgery beyond Technology – addressed [...]
Mood Disorders are a common, chronic, severe, complex and costly group of predominantly recurrent psychiatric illness that can be devastating for the affected individual and their families and impose a high health care related burden. Major depressive disorder and bipolar disorder are the main diagnostic categories in mood disorders. There is a significant clinical need [...]
Alzheimer’s disease (AD) is a major unmet medical need that requires innovation to be aligned with public health and health systems‘ needs. AD represents between 60 and%70% of the dementia cases. It is still diagnosed too late, when the symptoms become more evident as the disease progresses. AD is now portrayed as a continuum [...]
The International Congress for Ataxia Research (ICAR), to be held on 1-4 November 2022, will take place in Dallas, Texas (USA). This Congress will combine the best of our organizations’ popular research meetings, including NAF’s Ataxia Investigators Meeting (AIM) and the International Ataxia Research Conference (IARC), co-led by FARA, Ataxia UK, GoFAR, and other partner [...]
EBC as a member of the pan-European Mental Health Coalition (*) working package on mental health and well-being of children, adolescents and youth and in the framework of the joint Value of Treatment study on anorexia nervosa, autism and depression in Europe participated online in the Mental Health Week meeting that took place in [...]
The EU Health Coalition is delighted to invite you to its 3rd EU Health Summit to map the future of the European Health Union. The event will build on the stark lessons learned from COVID-19 and discuss how to go beyond the status-quo in health, seizing opportunities to make positive changes. It will ask what [...]
WHO/Europe held the second meeting of its Pan-European Mental Health Coalition on 23–24 November 2022 in Ankara, Turkey, jointly hosted with the fourth Annual Conference on Social Inclusion of Persons with Mental Disabilities. Held in hybrid format, the conference aimed to leverage regional momentum and continue advocating for the necessary actions to improve mental [...]